Advice

In the absence of a submission from the holder of the marketing authorisation:

timothy grass pollen allergen (GRAZAX®) is not recommended for use within NHS Scotland.

Indication under review: Disease-modifying treatment of grass pollen induced rhinitis and conjunctivitis in adults and children (5 years or older), with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this extension to the indication.  As a result we cannot recommend its use within NHSScotland.

Download detailed advice39KB (PDF)

Download

Medicine details

Medicine name:
timothy grass pollen allergen (GRAZAX)
SMC ID:
868/13
Indication:
Disease-modifying treatment of grass pollen induced rhinitis and conjunctivitis in adults and children (5 years or older), with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.
Pharmaceutical company
ALK-Abello Ltd
BNF chapter
Respiratory system
Submission type
Non submission
Status
Not recommended
Date advice published:
08 April 2013